**About the Editors**

#### **Antonio Carrillo-Vico**

Antonio Carrillo Vico (Ph.D.), B.S. in Biology by the University of Seville in 2005, Ph.D. in Cellular and Molecular Biology by the University of Seville in 2005 (Extraordinary award). He has held several positions as FEBS postdoctoral fellow, lecturer, and associate professor. He completed the postdoctoral period at the Institute of Immunology and Infection Research at the University of Edinburgh. He is full professor of the Department of Medical Biochemistry and Molecular Biology and Immunology at the Faculty of Medicine of the University of Seville and leads the Molecular NeuroInmunoEndocrinology research group at the Institute of Biomedicine of Seville (IBiS). The long-term goals of the Dr. Carrillo Vico research programme is to evaluate melatonin as a therapeutic tool in inflammatory pathologies and to determine the immunoendocrine actions of plant bioactive peptides. He has participated in more than 25 competitive research projects in the fields of biomedicine and science and food technology. He has a track record of publication of 65 JCR articles with 3700 citations and an h-index of 30 (WoS, June-2023). He is also author of books, book chapters, articles of scientific popularisation, and more than 50 communications at national and international congresses. He is also director of 11 Ph.D. theses. He is member of the Editorial Commitees of 3 journals and reviewer of more than 30 journals.

#### **Ivan Cruz-Chamorro**

Ivan Cruz-Chamorro (Ph.D.) is a post-doctoral researcher at the University of Seville, Spain. Since 2012, he has been a component of the Molecular Neuroimmunoendocrinology Laboratory of the Institute of Biomedicine of Seville (IBiS). In 2018, he discussed his doctoral thesis, "Assessment of the health effects of plant bioactive peptides: immunomodulatory, antioxidant, and metabolic effects", obtaining an outstanding *cum laude* rating. Ivan is involved in studying the biological effects (immunomodulators, antioxidants, lipid-lowering, etc.) of protein hydrolysates from several plant sources, such as lupine, olive, and hemp. He has directed a doctoral thesis in which the capacity of protein hydrolysate from lupine has been explored in the metabolic syndrome (MetS) and in the preclinical mouse model of hypercholesterolemia. Ivan collaborates with different international ´ groups and he is exploring the effects of different natural matrices on some diseases, such as MetS, metabolic-associated fatty liver disease, and multiple sclerosis. At last, his future objective is to explore the biological effects of these matrices on the cancer models.
